vglut1  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Alomone Labs vglut1
    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker <t>vGLUT1</t> (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vglut1/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vglut1 - by Bioz Stars, 2023-01
    93/100 stars

    Images

    1) Product Images from "Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation"

    Article Title: Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation

    Journal: The Journal of Neuroscience

    doi: 10.1523/JNEUROSCI.2981-19.2020

    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Figure Legend Snippet: Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).

    Techniques Used: Expressing, Marker, MANN-WHITNEY

    vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Alomone Labs vglut1
    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker <t>vGLUT1</t> (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vglut1/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vglut1 - by Bioz Stars, 2023-01
    93/100 stars

    Images

    1) Product Images from "Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation"

    Article Title: Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation

    Journal: The Journal of Neuroscience

    doi: 10.1523/JNEUROSCI.2981-19.2020

    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Figure Legend Snippet: Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).

    Techniques Used: Expressing, Marker, MANN-WHITNEY

    vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Alomone Labs vglut1
    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker <t>vGLUT1</t> (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vglut1/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vglut1 - by Bioz Stars, 2023-01
    86/100 stars

    Images

    1) Product Images from "Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation"

    Article Title: Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation

    Journal: The Journal of Neuroscience

    doi: 10.1523/JNEUROSCI.2981-19.2020

    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Figure Legend Snippet: Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).

    Techniques Used: Expressing, Marker, MANN-WHITNEY

    vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Alomone Labs vglut1
    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker <t>vGLUT1</t> (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vglut1/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vglut1 - by Bioz Stars, 2023-01
    86/100 stars

    Images

    1) Product Images from "Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation"

    Article Title: Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation

    Journal: The Journal of Neuroscience

    doi: 10.1523/JNEUROSCI.2981-19.2020

    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Figure Legend Snippet: Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).

    Techniques Used: Expressing, Marker, MANN-WHITNEY

    vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Alomone Labs vglut1
    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker <t>vGLUT1</t> (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vglut1/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vglut1 - by Bioz Stars, 2023-01
    86/100 stars

    Images

    1) Product Images from "Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation"

    Article Title: Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation

    Journal: The Journal of Neuroscience

    doi: 10.1523/JNEUROSCI.2981-19.2020

    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Figure Legend Snippet: Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).

    Techniques Used: Expressing, Marker, MANN-WHITNEY

    vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Alomone Labs vglut1
    Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vglut1/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vglut1 - by Bioz Stars, 2023-01
    93/100 stars

    Images

    vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Alomone Labs vglut1
    Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vglut1/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vglut1 - by Bioz Stars, 2023-01
    93/100 stars

    Images

    na v 1 2  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 88
      Buy from Supplier

    Structured Review

    Alomone Labs na v 1 2
    Na V 1 2, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/na v 1 2/product/Alomone Labs
    Average 88 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    na v 1 2 - by Bioz Stars, 2023-01
    88/100 stars

    Images

    anti vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Alomone Labs anti vglut1
    Table 1
    Anti Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti vglut1/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti vglut1 - by Bioz Stars, 2023-01
    86/100 stars

    Images

    1) Product Images from "Axotomy of tributaries of the pelvic and pudendal nerves induces changes in the neurochemistry of mouse dorsal root ganglion neurons and the spinal cord"

    Article Title: Axotomy of tributaries of the pelvic and pudendal nerves induces changes in the neurochemistry of mouse dorsal root ganglion neurons and the spinal cord

    Journal: Brain structure & function

    doi: 10.1007/s00429-015-1019-6

    Table 1
    Figure Legend Snippet: Table 1

    Techniques Used: Expressing

    anti vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 88
      Buy from Supplier

    Structured Review

    Alomone Labs anti vglut1
    Table 1
    Anti Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti vglut1/product/Alomone Labs
    Average 88 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti vglut1 - by Bioz Stars, 2023-01
    88/100 stars

    Images

    1) Product Images from "Axotomy of tributaries of the pelvic and pudendal nerves induces changes in the neurochemistry of mouse dorsal root ganglion neurons and the spinal cord"

    Article Title: Axotomy of tributaries of the pelvic and pudendal nerves induces changes in the neurochemistry of mouse dorsal root ganglion neurons and the spinal cord

    Journal: Brain structure & function

    doi: 10.1007/s00429-015-1019-6

    Table 1
    Figure Legend Snippet: Table 1

    Techniques Used: Expressing

    rabbit anti vglut1  (Alomone Labs)


    Bioz Verified Symbol Alomone Labs is a verified supplier
    Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 88
      Buy from Supplier

    Structured Review

    Alomone Labs rabbit anti vglut1
    Rabbit Anti Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti vglut1/product/Alomone Labs
    Average 88 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti vglut1 - by Bioz Stars, 2023-01
    88/100 stars

    Images

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • vglut1  (Alomone Labs)
    93
    Alomone Labs vglut1
    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker <t>vGLUT1</t> (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vglut1/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    vglut1 - by Bioz Stars, 2023-01
    93/100 stars
    		  Buy from Supplier
    na v 1 2  (Alomone Labs)
    88
    Alomone Labs na v 1 2
    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker <t>vGLUT1</t> (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).
    Na V 1 2, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/na v 1 2/product/Alomone Labs
    Average 88 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    na v 1 2 - by Bioz Stars, 2023-01
    88/100 stars
    		  Buy from Supplier
    anti vglut1  (Alomone Labs)
    86
    Alomone Labs anti vglut1
    Table 1
    Anti Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti vglut1/product/Alomone Labs
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti vglut1 - by Bioz Stars, 2023-01
    86/100 stars
    		  Buy from Supplier
    rabbit anti vglut1  (Alomone Labs)
    88
    Alomone Labs rabbit anti vglut1
    Table 1
    Rabbit Anti Vglut1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti vglut1/product/Alomone Labs
    Average 88 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti vglut1 - by Bioz Stars, 2023-01
    88/100 stars
    		  Buy from Supplier

    Image Search Results


    Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).

    Journal: The Journal of Neuroscience

    Article Title: Presynaptic L-Type Ca 2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation

    doi: 10.1523/JNEUROSCI.2981-19.2020

    Figure Lengend Snippet: Long-lasting LPS treatment increases the expression of L-type Ca2+ channels at glutamatergic synapses. A, Top, Representative images of neurites of hippocampal neurons exposed to either vehicle or LPS for 48 h and double-immunostained with Cav1.2 antibodies (green) and the excitatory presynaptic marker vGLUT1 (red). Merge panels represent synaptic puncta in which Cav1.2 and vGLUT1 colocalize (yellow; arrows). Bottom, Representative immunoreactivity intensity profiles of the colocalization experiments showing the increased occurrence of overlap between Cav1.2- and vGLUT1-positive puncta in the samples chronically treated with LPS. B, Quantification of the density of vGLUT1-positive puncta counted on 30 μm dendrite tracts starting from the neuronal body. Data are mean ± SEM from three independent experiments, each conducted in duplicate (veh = 30; LPS = 29). C, Quantification of the absolute Cav1.2/vGLUT1 colocalization area (top) and of the Cav1.2/vGLUT1 colocalization expressed in percent of the total Cav1.2-immunopositive area (bottom) in vehicle- and LPS-treated neurons (veh = 66; LPS = 97). Data are mean ± SEM. **p < 0.01 (unpaired Student's t test/Mann–Whitney U test).

    Article Snippet: The presynaptic localization of the L-type Ca 2+ channel was analyzed in treated neurons by evaluating the immunoreactivity of L-type Ca 2+ channel (1:200, Alomone Labs) ( Hermosilla et al., 2017 ) in vGLUT1-positive excitatory boutons.

    Techniques: Expressing, Marker, MANN-WHITNEY

    Table 1

    Journal: Brain structure & function

    Article Title: Axotomy of tributaries of the pelvic and pudendal nerves induces changes in the neurochemistry of mouse dorsal root ganglion neurons and the spinal cord

    doi: 10.1007/s00429-015-1019-6

    Figure Lengend Snippet: Table 1

    Article Snippet: Antibodies included rabbit anti-ATF3 (1:4000; sc-188, Santa Cruz, Dallas, TX, USA), anti-CGRP (1:12,000; C8198, Sigma, Saint Louis, MO, USA), anti-TRPV1 (1:4000; ACC-030, Alomone Labs, Jerusalem, Israel), anti-TH (1:4000; AB152, Millipore, Temecula, CA, USA), anti-VGLUT1 (1:4000; Brumovsky et al. 2007 , 2011a , b; Kawamura et al. 2006 ) or guinea pig anti-VGLUT2 (1:4000; Brumovsky et al. 2007 , 2011a , b; Miyazaki et al. 2003 ).

    Techniques: Expressing